IrisinEx-IrisinNCT07146490
Effects of Different Types of Exercise on Irisin and Cognitive Performance (Exercise-Irisin)
A study testing Low Exercise, Long Interval Exercise and Short Intevral Exercise in people with Irisin and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale. Method This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity… Read more about this study
- Who is it for?
- Ages 18 to 25 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Irisin, Lactate, Cognitive Function
- What is being tested?
- Low Exercise, Long Interval Exercise and Short Intevral Exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 12 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Jun 2025to 5 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Aged between 18 and 25 years
- No known medical condition that prevents participation in exercise
- Not currently using any pharmacological agents
Who cannot join
- Experiencing any discomfort before, during, or after exercise
- Current or past diagnosis of pharmacological or doping substance use
- Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
- History of alcohol or substance addiction
- Any other condition or factor that may prevent full participation in the study protocol
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Exercise Intensity on Neurochemical and Cognitive Function: The Role of Lactate and Irisin
Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale.
Method
Read more
This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity Interval Training (SI-HIIT), Long-Interval High-Intensity Interval Training (LI-HIIT) and Low-Intensity Continuous Training (LICT), on cognitive performance (via the Trial Making Test, ) and associated neurochemical responses (e.g., serum Irisin and blood lactate levels) in healthy young adults aged 18-25 years.
All participants completed the three conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of three groups (n = 4 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-3) and that the order minimized sequence effects by rotating the position of each condition relative to the others.
To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (Irisin increases reported -no two high-intensity sessions were scheduled consecutively. Where possible, higher and lower intensity protocols were be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.
The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis.
All exercise sessions conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.
During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.
In the following four visits, each participant completed all experimental conditions. Each exercise session began with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.
All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.
- Short-interval high-Intensity Interval Training: Participants ran at 110-120% of their MAS for 15-second intervals.
- Long-interval high-Intensity Interval Training: Participants ran at a speed corresponding to 80-90% of their MAS.
- Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.
Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Trial Making Test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Feeling Scale.
- Conditions
- Irisin, Lactate, Cognitive Function, Exercise Training
- Being tested
- Low Exercise, Long Interval Exercise, Short Intevral Exercise
- Keywords
- HIIT, Irisin, Lactate, Cognitive Function
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low ExerciseBehavioural
Low-Intensity Continuous Training (LICT): Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.
Long Interval ExerciseBehavioural
Long-interval high-Intensity Interval Training (LI-HIIT): Participants ran at a speed corresponding to 80-90% of their MAS. The protocol consisted of four 4-minute bouts, separated by 2-minute active recovery periods, during which participants ran at 50% of their MAS. This pattern totaled 24 minutes of exercise.
Short Intevral ExerciseBehavioural
Short-interval high-Intensity Interval Training (SI-HIIT): Participants ran at 110-120% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they rested passively for 15 seconds and returned to their starting point. This was repeated continuously for 3 minutes, constituting one set. A total of four 3-minute sets were completed, interspersed with 3-minute passive rest periods, yielding a total exercise time of 24 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Low-Intensity Continuous Training Group (n=4) | Experimental | They were asked to perform low intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. Receives: Behavioral: Low Exercise |
| Long-interval high-Intensity Interval Training Group (n=4) | Experimental | They were asked to perform long interval moderate intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. Receives: Behavioral: Long Interval Exercise |
| Short-interval high-Intensity Interval Training Group (n=4) | Experimental | They were asked to perform short interval high intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. Receives: Behavioral: Short Intevral Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lactate
Lactate levels were measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer.
Measured: Baseline and immediately after exercise (Day 1)
Irisin
Irisin levels were measured using a Sunred brand ELISA kit from blood samples taken baseline and after exercise, and the results were reported in pg/mL units.
Measured: Baseline and immediately after exercise (Day 1)
Trial Making Test
The Trail Making Test (TMT) is a widely used neuropsychological assessment tool to evaluate attention, visual scanning, processing speed, mental flexibility, and executive function.
TMT-A measures processing speed and visual attention by requiring participants to connect sequential numbers (1-25) as quickly as possible. Completion times were recorded in seconds.
TMT-B measures cognitive flexibility and executive control by requiring participants to alternate between numbers and letters (1-A-2-B, etc.).
Measured: Baseline and immediately after exercise (Day 1)
Feeling Scale
The Feeling Scale (FS) is a single-item measure of affective valence during or after exercise. Participants are asked, "How are you feeling right now?" and respond on an 11-point bipolar scale ranging from -5 to +5.
Scoring:
-5 = Very Bad
0 = Neutral
+5 = Very Good
Negative scores indicate unpleasant affect, whereas positive scores indicate pleasant affect. Higher scores reflect better subjective feelings.
Measured: Baseline and immediately after exercise (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Aug 2025
- Study start10 Jun 2025
- Primary completion27 Jul 2025
- Study completion5 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for IrisinStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aksaray University Training and Research Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, serkan pancar, Aksaray University Training and Research Hospital
- Investigators
- serkan PANCAR, Assistant Professor, Study director, Aksaray University /Faculty of Sports Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07146490
- Sponsor's protocol ID
- 10.03
- Acronym
- Ex-Irisin
- Status last verified
- Aug 2025
- First submitted
- 20 Aug 2025
- Last updated
- 4 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Exercise Intensity on Neurochemical and Cognitive Function: The Role of Lactate and Irisin
- ClinicalTrials.gov ID
- NCT07146490
- Acronym / sponsor ID
- Ex-Irisin / 10.03
- Conditions
- Irisin, Lactate, Cognitive Function, Exercise Training
- Keywords
- HIIT, Irisin, Lactate, Cognitive Function
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Aksaray University Training and Research HospitalUniversity, hospital or other
- Study start
- 10 Jun 2025 (actual)
- Primary completion
- 27 Jul 2025 (actual)
- Study completion
- 5 Aug 2025 (actual)
- First posted
- 28 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale.
Method
This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity Interval Training (SI-HIIT), Long-Interval High-Intensity Interval Training (LI-HIIT) and Low-Intensity Continuous Training (LICT), on cognitive performance (via the Trial Making Test, ) and associated neurochemical responses (e.g., serum Irisin and blood lactate levels) in healthy young adults aged 18-25 years.
All participants completed the three conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of three groups (n = 4 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-3) and that the order minimized sequence effects by rotating the position of each condition relative to the others.
To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (Irisin increases reported -no two high-intensity sessions were scheduled consecutively. Where possible, higher and lower intensity protocols were be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.
The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis.
All exercise sessions conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.
During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.
In the following four visits, each participant completed all experimental conditions. Each exercise session began with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.
All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.
- Short-interval high-Intensity Interval Training: Participants ran at 110-120% of their MAS for 15-second intervals.
- Long-interval high-Intensity Interval Training: Participants ran at a speed corresponding to 80-90% of their MAS.
- Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.
Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Trial Making Test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Feeling Scale.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Low-Intensity Continuous Training Group (n=4) | Experimental | Behavioral: Low ExerciseThey were asked to perform low intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. |
| Long-interval high-Intensity Interval Training Group (n=4) | Experimental | Behavioral: Long Interval ExerciseThey were asked to perform long interval moderate intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. |
| Short-interval high-Intensity Interval Training Group (n=4) | Experimental | Behavioral: Short Intevral ExerciseThey were asked to perform short interval high intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Aged between 18 and 25 years
- No known medical condition that prevents participation in exercise
- Not currently using any pharmacological agents
Key exclusion criteria (5 listed)
- Experiencing any discomfort before, during, or after exercise
- Current or past diagnosis of pharmacological or doping substance use
- Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
- History of alcohol or substance addiction
- Any other condition or factor that may prevent full participation in the study protocol
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low ExerciseLow-Intensity Continuous Training (LICT): Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks. | Behavioural | Low-Intensity Continuous Training Group (n=4) |
| Long Interval ExerciseLong-interval high-Intensity Interval Training (LI-HIIT): Participants ran at a speed corresponding to 80-90% of their MAS. The protocol consisted of four 4-minute bouts, separated by 2-minute active recovery periods, during which participants ran at 50% of their MAS. This pattern totaled 24 minutes of exercise. | Behavioural | Long-interval high-Intensity Interval Training Group (n=4) |
| Short Intevral ExerciseShort-interval high-Intensity Interval Training (SI-HIIT): Participants ran at 110-120% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they rested passively for 15 seconds and returned to their starting point. This was repeated continuously for 3 minutes, constituting one set. A total of four 3-minute sets were completed, interspersed with 3-minute passive rest periods, yielding a total exercise time of 24 minutes. | Behavioural | Short-interval high-Intensity Interval Training Group (n=4) |
Primary outcome
Lactate
Time frame: Baseline and immediately after exercise (Day 1)
Lactate levels were measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer.
Irisin
Time frame: Baseline and immediately after exercise (Day 1)
Irisin levels were measured using a Sunred brand ELISA kit from blood samples taken baseline and after exercise, and the results were reported in pg/mL units.
Trial Making Test
Time frame: Baseline and immediately after exercise (Day 1)
The Trail Making Test (TMT) is a widely used neuropsychological assessment tool to evaluate attention, visual scanning, processing speed, mental flexibility, and executive function. TMT-A measures processing speed and visual attention by requiring participants to connect sequential numbers (1-25) as quickly as possible. Completion times were recorded in seconds. TMT-B measures cognitive flexibility and executive control by requiring participants to alternate between numbers and letters (1-A-2-B, etc.).
Feeling Scale
Time frame: Baseline and immediately after exercise (Day 1)
The Feeling Scale (FS) is a single-item measure of affective valence during or after exercise. Participants are asked, "How are you feeling right now?" and respond on an 11-point bipolar scale ranging from -5 to +5. Scoring: -5 = Very Bad 0 = Neutral +5 = Very Good Negative scores indicate unpleasant affect, whereas positive scores indicate pleasant affect. Higher scores reflect better subjective feelings.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Irisin
Not yet recruiting
Virtual Reality Training Dose for Arm Recovery After Stroke: Clinical and Blood Biomarker Responses
Stroke, Upper Extremity Paresis
Not yet recruiting
Effect of Intracanal Cryotherapy on Pain, Anxiety, and Salivary Irisin After Root Canal Treatment
Postoperative Pain After Endodontic Treatment, Dental Anxiety
Not yet recruiting
Effects of Different Exercise Types on Irisin, Leptin, and Ghrelin Levels in Sedentary Women
Exercise Physiology, Metabolic Hormones
Not yet recruitingObservational study
Salivary and GCF Biomarkers in Periodontal Health, Gingivitis and Periodontitis
Periodontal Health, Gingivitis
Not yet recruiting
The Impact of Exercise on Irisin-BDNF Regulation in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
serkan PANCAR, Assistant Professor study director
Aksaray University /Faculty of Sports Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low Exercise, Long Interval Exercise and Short Intevral Exercise in people with Irisin and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lactate (time frame: Baseline and immediately after exercise (Day 1)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.